Cargando…

A Soluble Form of B Cell Maturation Antigen, a Receptor for the Tumor Necrosis Factor Family Member April, Inhibits Tumor Cell Growth

A proliferation-inducing ligand (APRIL) is a ligand of the tumor necrosis factor (TNF) family that stimulates tumor cell growth in vitro and in vivo. Expression of APRIL is highly upregulated in many tumors including colon and prostate carcinomas. Here we identify B cell maturation antigen (BCMA) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rennert, Paul, Schneider, Pascal, Cachero, Teresa G., Thompson, Jeffrey, Trabach, Luciana, Hertig, Sylvie, Holler, Nils, Qian, Fang, Mullen, Colleen, Strauch, Kathy, Browning, Jeffrey L., Ambrose, Christine, Tschopp, Jürg
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2000
Materias:	Brief Definitive Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193103/ https://www.ncbi.nlm.nih.gov/pubmed/11104810

Ejemplares similares

APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth
por: Hahne, Michael, et al.
Publicado: (1998)

Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population
por: Thompson, Jeffrey S., et al.
Publicado: (2000)

Maturation of Marginal Zone and Follicular B Cells Requires B Cell Activating Factor of the Tumor Necrosis Factor Family and Is Independent of B Cell Maturation Antigen
por: Schneider, Pascal, et al.
Publicado: (2001)

BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth
por: Schneider, Pascal, et al.
Publicado: (1999)

Identification of proteoglycans as the APRIL-specific binding partners
por: Ingold, Karine, et al.
Publicado: (2005)

The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor κB Activation by Tumor Necrosis Factor
por: Regamey, Alexandre, et al.
Publicado: (2003)

Leptin Is an Endogenous Protective Protein against the Toxicity Exerted by Tumor Necrosis Factor
por: Takahashi, Nozomi, et al.
Publicado: (1999)

A Mediator Role For Metallothionein in Tumor Necrosis Factor–induced Lethal Shock
por: Waelput, Wim, et al.
Publicado: (2001)

Type I interferon drives tumor necrosis factor–induced lethal shock
por: Huys, Liesbeth, et al.
Publicado: (2009)

Essential Role of Nuclear Factor (NF)-κB–Inducing Kinase and Inhibitor of κb (Iκb) Kinase α in Nf-κb Activation through Lymphotoxin β Receptor, but Not through Tumor Necrosis Factor Receptor I
por: Matsushima, Akemi, et al.
Publicado: (2001)

Caspase Activation Is Required for T Cell Proliferation
por: Kennedy, Norman J., et al.
Publicado: (1999)

Baff Mediates Survival of Peripheral Immature B Lymphocytes
por: Batten, Marcel, et al.
Publicado: (2000)

Tumor Necrosis Factor α and Lymphotoxin α Are Not Required for Induction of Acute Experimental Autoimmune Encephalomyelitis
por: Frei, Karl, et al.
Publicado: (1997)

Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4
por: Burns, Kimberly, et al.
Publicado: (2003)

Requirement of Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 in Interleukin 17 Signal Transduction
por: Schwandner, Ralf, et al.
Publicado: (2000)

Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors
por: Pronk, Cornelis J.H., et al.
Publicado: (2011)

Antiviral Activity of Tumor Necrosis Factor (TNF) Is Mediated via p55 and p75 TNF Receptors
por: Ruby, Janet, et al.
Publicado: (1997)

Critical Points of Tumor Necrosis Factor Action in Central Nervous System Autoimmune Inflammation Defined by Gene Targeting
por: Körner, Heinrich, et al.
Publicado: (1997)

Tumor-derived soluble CD155 inhibits DNAM-1–mediated antitumor activity of natural killer cells
por: Okumura, Genki, et al.
Publicado: (2020)

Locally Up-regulated Lymphotoxin α, Not Systemic Tumor Necrosis Factor α, Is the Principle Mediator of Murine Cerebral Malaria
por: Engwerda, Christian R., et al.
Publicado: (2002)

Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α
por: Boyman, Onur, et al.
Publicado: (2004)

In Vitro– and Ex Vivo–derived Cytolytic Leukocytes from Granzyme A × B Double Knockout Mice Are Defective in Granule-mediated Apoptosis but not Lysis of Target Cells
por: Simon, Markus M., et al.
Publicado: (1997)

Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells
por: Notley, Clare A., et al.
Publicado: (2008)

Taci Is a Traf-Interacting Receptor for Tall-1, a Tumor Necrosis Factor Family Member Involved in B Cell Regulation
por: Xia, Xing-Zhong, et al.
Publicado: (2000)

Prostaglandin E2 and Tumor Necrosis Factor α Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 Production
por: Rieser, Claudia, et al.
Publicado: (1997)

Inducing Tumor Immunity through the Selective Engagement of Activating Fcγ Receptors on Dendritic Cells
por: Kalergis, Alexis M., et al.
Publicado: (2002)

Reversal of Spontaneous Autoimmune Insulitis in Nonobese Diabetic Mice by Soluble Lymphotoxin Receptor
por: Wu, Qiang, et al.
Publicado: (2001)

Stimulus-dependent Synergism of the Antiapoptotic Tumor Necrosis Factor Receptor–associated Factor 2 (TRAF2) and Nuclear Factor κB Pathways
por: Lee, Soo Young, et al.
Publicado: (1998)

FAS Engagement Induces the Maturation of Dendritic Cells (Dcs), the Release of Interleukin (Il)-1β, and the Production of Interferon γ in the Absence of IL-12 during Dc–T Cell Cognate Interaction: A New Role for FAS Ligand in Inflammatory Responses
por: Rescigno, Maria, et al.
Publicado: (2000)

Immune Cell Activation by Bacterial Cpg-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor–Associated Factor (Traf)6
por: Häcker, Hans, et al.
Publicado: (2000)

Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis
por: Stehlik, Christian, et al.
Publicado: (1998)

The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6)
por: Muzio, Marta, et al.
Publicado: (1998)

TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor
por: Wong, Brian R., et al.
Publicado: (1997)

Critical Contribution of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) to Apoptosis of Human Cd4(+)T Cells in HIV-1–Infected Hu-Pbl-Nod-Scid Mice
por: Miura, Yoshiharu, et al.
Publicado: (2001)

Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
por: Mackay, Fabienne, et al.
Publicado: (1999)

Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors
por: Ashley, David M., et al.
Publicado: (1997)

Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity
por: Schneider, Pascal, et al.
Publicado: (1998)

Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo
por: Ingram, David A., et al.
Publicado: (2000)

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors
Publicado: (1992)

Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use
por: Lim, Mie Jin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2m9771igcl4prrr3gokdrht9uv